Remove Acquisition Remove Capital Remove Company Remove Enterprise Partners
article thumbnail

Enterprise Partners Portfolio Firm Heads Towards IPO

socalTECH

One of the portfolio firms of San Diego venture capital firm Enterprise Partners is heading towards an IPO, according to a S-1 filing Friday. The IPO is being underwritten by UBS Investment Bank, Jefferies & Company, Baird, and Cowen and Company.

article thumbnail

Enterprise Partners Portfolio Firm Heads To Market

socalTECH

One of the portfolio firms of San Diego-based venture capital firm Enterprise Partners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. per share for the company. Enterprise Partners owns about 14.8 per share, below an earlier estimated range of $12.00

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

XIFIN Buys PathCentral

socalTECH

San Diego-based XIFIN , which develops cloud-based financial software for the healthcare industry, has acquired Irvine-based PathCentral , a developer of software for the pathology community, the company announced Thursday afternoon. Financial details of the acquisition were not announced. READ MORE>>.

Windward 138
article thumbnail

Celladon Files For IPO

socalTECH

The company said it is looking to raise up to $86.25M in an offering on the NASDAQ Global Market, trading under the symbol CLDN. The company''s IPO is being underwritten by J.P. The company''s enzymes are targeted at diseases involving issues with regulation of calcium, including heart failure. READ MORE>>.

article thumbnail

XIFIN Acquired By GTCR

socalTECH

GTCR said that founder and CEO Lale White will continue to lead the company. billion GTCR Fund XI, with additional funding provided by GE Capital and CapitalSource. XIFIN''s backers include Boulder Ventures, Enterprise Partners, and Windward Ventures. GTCR said the investment came from its $3.85 READ MORE>>.

Windward 138
article thumbnail

TargeGen Acquired By Sanofi-aventis

socalTECH

Pappas & Associates, BB Biotech Ventures, CDIB Ventures, CDP Capital Technology Ventures, Chicago Growth Partners, CTI Life Sciences Fund, Enterprise Partners, Forward Ventures, H&Q Investments, Innovis Investments, Pappas Ventures, VantagePoint Venture Partners, and William Blair Capital Partners.